EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of Venous Thromboembolism Risk with Atopic Dermatitis and Janus Kinase Inhibitors Treatment: A Mendelian Randomization Study

Zhiqiang Chen, Shuaibo Wang, Yifei Wang iD

Clinical and Applied Thrombosis/Hemostasis · 2026

DOI: 10.1177/10760296251413253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2026. Verfasst von Zhiqiang Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, the Fuyang Affiliated Hospital of Anhui Medical University, Fuyang, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Venous Thromboembolism, Janus Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anhui Provincial Health Commission Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The risk of venous thromboembolism (VTE) among patients with atopic dermatitis (AD), especially when receiving treatment with Janus kinase inhibitors (JAKi), has been reported in observational studies. however, the causal relationships between them remain unclear. We aim to explore the causal effects of AD and JAKi on VTE, including deep vein thrombosis (DVT) and pulmonary embolism (PE).

Methods

Two-sample Mendelian randomization (MR) analyses were conducted to examine the causal between genetic susceptibility to AD or JAKi target genes (including JAK1, JAK2, JAK3 and tyrosine kinase 2 [TYK2]) and VTE (encompassing DVT and PE) using summary statistics from genome-wide association studies and eQTLGen project. Inverse variance weighting with random effect method was used as the main analytic approach. Pleiotropy and heterogeneity tests were conducted to assess the robustness of the findings.

Results

No significant causal effects were found between AD and the risk of (odds ratio [OR]: 0.97, 95% confidence interval [CI]: 0.91-1.03, P = .352), DVT (OR: 0.99, 95% CI: 0.89-1.10, P = .789), and PE (OR: 1.06, 95% CI: 0.93-1.20, P = .387). Similarly, there was no causal association between the expression of JAK1, JAK2, JAK3 or TYK2 and VTE, DVT and PE.

Conclusion

The MR analysis revealed no genetic causal relationships between either AD or JAKi target genes and VTE. These findings may provide a reference for clinicians in prescribing JAKi for patients with AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicVenous ThromboembolismJanus Kinase InhibitorsHumansMendelian Randomization AnalysisRisk FactorsMale

Stichwörter der Autor:innen

Janus kinase inhibitorsMendelian randomizationatopic dermatitisvenous thromboembolism

Substanzen

Janus Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Vascular Surgery, the Fuyang Affiliated Hospital of Anhui Medical University, Fuyang, China.
  • College of Clinical Medicine, North Henan Medical University, Xinxiang, China.
  • Department of Dermatology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.

ORCID-Profile: Yifei Wang

Förderung

  • Anhui Provincial Health Commission Scientific Research Project

Zitieren

APA

Chen, Z., Wang, S., & Wang, Y. (2026). Association of Venous Thromboembolism Risk with Atopic Dermatitis and Janus Kinase Inhibitors Treatment: A Mendelian Randomization Study. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296251413253

Vancouver

Chen Z, Wang S, Wang Y. Association of Venous Thromboembolism Risk with Atopic Dermatitis and Janus Kinase Inhibitors Treatment: A Mendelian Randomization Study. Clinical and Applied Thrombosis/Hemostasis. 2026. doi:10.1177/10760296251413253

BibTeX
@article{Chen2026,
  author = {Chen, Zhiqiang and Wang, Shuaibo and Wang, Yifei},
  title = {Association of Venous Thromboembolism Risk with Atopic Dermatitis and Janus Kinase Inhibitors Treatment: A Mendelian Randomization Study},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2026},
  doi = {10.1177/10760296251413253}
}
Kostenlos starten →